Skip to main content
. 2011 Aug 26;118(17):4561–4566. doi: 10.1182/blood-2011-04-348888

Table 2.

Distribution of adult AML patients in risk categories by IDH1 SNP status

IDH1 SNP+ (n = 21)
IDH1 SNP (n = 165)
N % N %
Favorable risk
    CBF AML 0 0 20 12
    CN, FLT3 1 5 41 25
Adverse risk
    CN, FLT3+ 9 43 29 18
    Any other cytogenetics 11 52 75 45